109 results about "New diagnosis" patented technology

The invention discloses application of asparagine with AKAP4 protein 186th-site generating mass shift -114.04278 as a biological marker in preparing a reagent for diagnosing severe oligoasthenospermia. The fact that the detection frequency of the AKAP4 protein 186th-site generating mass shift -114.04278 can be used for diagnosing the severe oligoasthenospermia is found, so that a new diagnosis and treatment target is provided for the severe oligoasthenospermia.

The present invention is drawn to a new diagnosis method for detecting the extent of hepatic steatosis in a patient, in particular in a patient who suffers from a disease involving hepatic steatosis, or who already had a positive diagnosis test of liver fibrosis and / or presence of liver necroinflammatory lesions, by using the serum concentration of easily detectable biological markers. The invention is also drawn to diagnosis kits for the implementation of the method.

In transmissions of each frame through intermittent transmissions, by performing ultrasonic wave transmissions while increasing a mechanical function step by step, destructions of bubbles of a contrast medium can be induced step by step according to their different sizes. By generating ultrasonic images using the destructions at the respective steps as the sources of echoes, it is possible to provide new ecological information including, for example, information reflecting the dynamics of substances smaller than the red blood cells, the distribution of predatory cells, new diagnosis information, etc.

The invention relates to a serum surface enhanced Raman spectrum based parotid tumor diagnosis technology, which is a novel technology directed at parotid tumor diagnosis by head and neck tumor surgery and oral and maxillofacial surgery. The technology mainly solves the problem that a conventional biopsy technique cannot be employed for definite diagnosis of parotid tumor patients before operation, replaces the parotid tumor local puncture biopsy technology, avoids complications caused thereby, simultaneously alleviates the work intensity of pathologists, and provides the basis for surgeons to adopt different operative treatment modes according to the benign / malignant nature of tumors. According to the technology, nanoscale gold sol particles are added into parotid tumor patient serum to enhance the intensity of a Raman spectrum so as to obtain a characteristic surface enhanced Raman spectrum of the tumor patient serum. Through analysis of a support vector machine on characteristic spectral data, a differential diagnosis model can be established for identifying different parotid tumors and providing the objective basis for preoperative diagnosis, thus establishing a quick and noninvasive new diagnosis technique.

The invention belongs to the field of biomedicine, and particularly relates to an up-stream open reading frame (uORF) of a phosphatase and tensin homolog (PTEN) gene, and applications of a protein encoded by the uORF. According to the present invention, the 5'UTR of PTEN has a potential 138-base open reading frame (45aa-uORF), wherein the 138-base open reading frame can encode a short peptide having 45 amino acids (named PTEN-45aa), and the short peptide has important effects in the occurrence and development process of tumors; and the new diagnosis, the new treatment method and the new drug screening platform are provided for diseases associated with PTEN expression regulation, particularly gliomas. The invention further provides a polypeptide for treating diseases associated with PTEN expression regulation.

The present invention is drawn to a new diagnosis method for detecting the extent of alcoholic or non-alcoholic steato-hepatitis in a patient, in particular in a patient suffering from a disease involving alcoholic or non-alcoholic steato-hepatitis or who already had a positive diagnosis test of liver fibrosis and / or presence of liver necroinfiammatory lesions, by using the serum concentration of easily detectable biological markers. The invention is also drawn to diagnosis kits for the implementation of the method.

The present invention is drawn to a new diagnosis method for detecting the extent of hepatic steatosis in a patient, in particular in a patient who suffers from a disease involving hepatic steatosis, or who already had a positive diagnosis test of liver fibrosis and / or presence of liver necroinflammatory lesions, by using the serum concentration of easily detectable biological markers. The invention is also drawn to diagnosis kits for the implementation of the method.

The invention discloses a method for achieving the automobile diagnosis and work project determination in a network questionnaire mode. The method comprises the steps that a car owner logs in an automobile diagnosis cloud server to obtain a questionnaire; the automobile diagnosis cloud server obtains the actual condition information of a car in a mode that the car owner fills in the questionnaire, and correspondingly searches and analyzes an automobile diagnosis cloud server database according to the car condition information in the questionnaire; the diagnosis result and work project are correspondingly extracted if there is the same car condition information, and the server correspondingly pushes the diagnosis result to a mobile terminal of the car owner; a mobile terminal of a maintainer is correspondingly used for diagnosis and analysis of the car condition information if there is no identical car condition information, and a new diagnosis result and work project are generated; and the correspondingly server pushes the diagnosis result to the mobile terminal of the car owner, and completes the request of work project maintenance. The method greatly meets the demands for the timely and accurate understanding of the actual car conditions during car diagnosis, and avoids the excessive maintenance.